Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Quantum Materials Corp. (QTMM) Message Board

"We learned Neurolytixs acknowledges QTMM as a par

Message Board Public Reply | Private Reply | Keep | Replies (3)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 22465
(Total Views: 669)
Posted On: 09/27/2021 11:17:16 AM
Posted By: TedJ
Re: drugmanrx #20971
"We learned Neurolytixs acknowledges QTMM as a partner and they do in fact hold patents for brain disease/injuries biomarkers.

If nothing else it adds credibility to QTMM lastest update."

As Squires stated in the last updated, Neurolytixs has pending patents. The bottom 3 are clearly provisional since they start with 62- and have not been published.

The first patent is an application https://patents.google.com/patent/WO201614980...6%2f149808 which has been published but is still pending. Looking deeper at https://portal.uspto.gov/pair/PublicPair , the US Application 15/560,056 was given a non-final rejection in June 2021 and an amendment was submitted in September.

Also note that the application has been assigned to LONDON HEALTH SCIENCES CENTRE RESEARCH INC by the inventors. It looks like Neurolytics is licensing the tech from London Health.

Quote:
Neurolytixs Intellectual Property (Patents)

METABOLOMICS PROFILING OF CENTRAL NERVOUS SYSTEM INJURY (2016), WO 2016/149808

DETERMINING CENTRAL NERVOUS SYSTEM INJURY AND RECOVERY (2020), 62/988169

DIAGNOSIS AND THERAPY OF TRAUMATIC BRAIN INJURY (2020), 63/104680

DETERMINING MILD TRAUMATIC BRAIN INJURY, RECOVERY AND TREATMENT (2021), 63/211771



(0)
(0)




Quantum Materials Corp. (QTMM) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us